Minimal Invasive Spinal Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$4000
Buy Report Download FREE Resources

Published: August 21, 2023 Report Code: GDME1608EPD-ST

Select Item

Minimal Invasive Spinal Devices Pipeline Market Overview

Minimally Invasive Spine (MIS) fusion surgery is performed to stabilize the vertebral bones and joints using devices such as Cannulated and non-Cannulated screws. MIS fusion surgery features shorter incisions and faster recovery time when compared to traditional or open procedures. In the segment, we have covered four minimally invasive spine surgery techniques: Mini-open, Percutaneous, Tubular, and Distally Expanding.

The Minimal Invasive Spinal Devices pipeline market research report provides comprehensive information about the pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.

Key Segments ·       Interbody Cages

·       Cannulated Screws

·       Rods
Key Territories ·       The US

·       China

·       Europe

·       Global

·       Taiwan

·       Switzerland
Key Regulatory Paths ·       510(k)

·       NMPA

·       CE

·       PMA

·       BOPA
Leading Companies ·       Bonovo Orthopedics Inc

·       Camber Spine Technologies LLC

·       Corelink LLC

·       CTL Amedica Corp

·       DePuy Synthes Inc
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Minimal Invasive Spinal Devices Pipeline Market Segmentation by Segments

Some of the key segments in the Minimal Invasive Spinal Devices market are interbody cages, cannulated screws, and rods. As of August 2023, interbody cages is the leading segment in the market.

Minimal Invasive Spinal Devices Pipeline Market Analysis by Segments, 2023 (%)

Minimal Invasive Spinal Devices Pipeline Market Analysis by Segments, 2023 (%)

Buy Full Report for More Segment Insights into The Minimal Invasive Spinal Devices Pipeline Market, Download a Free Report Sample

Minimal Invasive Spinal Devices Pipeline Market Segmentation by Territories

Some of the key territories in the Minimal Invasive Spinal Devices market are the US, China, , Europe, Switzerland, and Taiwan. As of August 2023, the US accounts for the highest number of Minimal Invasive Spinal Devices pipeline products.

Minimal Invasive Spinal Devices Pipeline Market Analysis by Territories, 2023 (%)

Minimal Invasive Spinal Devices Pipeline Market Analysis by Territories, 2023 (%)

Buy Full Report for More Territory Insights into The Minimal Invasive Spinal Devices Pipeline Market, Download a Free Report Sample

Minimal Invasive Spinal Devices Pipeline Market Segmentation by Regulatory Paths

Some of the key regulatory paths in the Minimal Invasive Spinal Devices pipeline market are 510(k), NMPA, CE, PMA, and BOPA among others. As of August 2023, 510(k) is the most followed pathway for pipeline products.

Minimal Invasive Spinal Devices Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Minimal Invasive Spinal Devices Pipeline Market Analysis by Regulatory Paths, 2023 (%)

Buy Full Report for More Regulatory Path Insights into The Minimal Invasive Spinal Devices Pipeline Market, Download a Free Report Sample

Minimal Invasive Spinal Devices Pipeline Market – Competitive Landscape

Some of the key companies in the Minimal Invasive Spinal Devices pipeline market are Bonovo Orthopedics Inc, Camber Spine Technologies LLC, Corelink LLC, CTL Amedica Corp, and DePuy Synthes Inc among others.

Bonovo Orthopedics Inc.: Bonovo Orthopedics Inc (Bonovo) is a medical device company that offers joint care products. The company develops and manufactures orthopedic implants and other orthopedic products to the Chinese healthcare market. It provides artificial discs, plates, fixation systems, cages, hip systems, artificial joints, surgical headlights, and instruments. Bonovo offers services such as product positioning and market analysis testing and validation marketing and distribution and Chinese regulatory expertise. The company also provides spinal implants, pain management products and minimally invasive surgical solutions. It markets products through a network of distributors in China. The company operates its manufacturing facilities in Beijing and Tianjin, China. It operates offices in the US and China. Bonovo is headquartered in Beijing, China.

Leading Minimal Invasive Spinal Devices Companies, 2023

Leading Minimal Invasive Spinal Devices Companies, 2023

Buy Full Report for More Company Insights into The Minimal Invasive Spinal Devices Pipeline Market, Download a Free Report Sample

Minimal Invasive Spinal Devices Pipeline Market Segments

Minimal Invasive Spinal Devices Pipeline Market Segments Outlook, (%, 2023)

  • Interbody Cages
  • Cannulated Screws
  • Rods

Minimal Invasive Spinal Devices Pipeline Market Territories Outlook, (%, 2023)

  • The US
  • China
  • Europe
  • Global
  • Taiwan
  • Switzerland

Minimal Invasive Spinal Devices Pipeline Market Regulatory Paths Outlook, (%, 2023)

  • NMPA
  • 510(k)
  • CE
  • PMA
  • BOPA

Scope

This report provides:

  • Extensive coverage of the Minimal Invasive Spinal Devices under development.

  • Details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities.

  • Reviews of the major players involved in the development of Minimal Invasive Spinal Devices and lists of all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage.

  • Key clinical trial data of ongoing trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of Minimal Invasive Spinal Devices under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • In-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Bonovo Orthopedics Inc
Camber Spine Technologies LLC
Corelink LLC
CTL Amedica Corp
DePuy Synthes Inc
Discure Technologies Ltd
EIT Emerging Implant Technologies GmbH
H. Lee Moffitt Cancer Center & Research Institute Inc
Implanet SA
Inion Oy
Integra LifeSciences Holdings Corp
Intelligent Implants
Maxigen Biotech Inc
MicroPort Scientific Corp
OrthoPediatrics Corp
Osseus Fusion Systems LLC
OxSonics Ltd
Safe SA
SeaSpine, Inc.
Spinal Balance Inc.
Stryker Corp
SurGenTec LLC
The Chaim Sheba Medical Center
University of South Florida
University of Toledo
Vivonics Inc
ZuriMED Technologies AG

Table of Contents

  • 1 Table of Contents

    • 1.1 List of Tables

    • 1.2 List of Figures

  • 2 Introduction

    • 2.1 Minimal Invasive Spinal Devices Overview

  • 3 Products under Development

    • 3.1 Minimal Invasive Spinal Devices – Pipeline Products by Stage of Development

    • 3.2 Minimal Invasive Spinal Devices – Pipeline Products by Segment

    • 3.3 Minimal Invasive Spinal Devices – Pipeline Products by Territory

    • 3.4 Minimal Invasive Spinal Devices – Pipeline Products by Regulatory Path

    • 3.5 Minimal Invasive Spinal Devices – Pipeline Products by Estimated Approval Date

    • 3.6 Minimal Invasive Spinal Devices – Ongoing Clinical Trials

  • 4 Minimal Invasive Spinal Devices – Pipeline Products under Development by Companies

    • 4.1 Minimal Invasive Spinal Devices Companies – Pipeline Products by Stage of Development

    • 4.2 Minimal Invasive Spinal Devices – Pipeline Products by Stage of Development

  • 5 Minimal Invasive Spinal Devices Companies and Product Overview

    • 5.1 Bonovo Orthopedics Inc Company Overview

      • 5.1.1 Bonovo Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2 Camber Spine Technologies LLC Company Overview

      • 5.2.1 Camber Spine Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3 Corelink LLC Company Overview

      • 5.3.1 Corelink LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4 CTL Amedica Corp Company Overview

      • 5.4.1 CTL Amedica Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5 DePuy Synthes Inc Company Overview

      • 5.5.1 DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6 Discure Technologies Ltd Company Overview

      • 5.6.1 Discure Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7 EIT Emerging Implant Technologies GmbH Company Overview

      • 5.7.1 EIT Emerging Implant Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8 H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview

      • 5.8.1 H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9 Implanet SA Company Overview

      • 5.9.1 Implanet SA Pipeline Products & Ongoing Clinical Trials Overview

    • 5.10 Inion Oy Company Overview

      • 5.10.1 Inion Oy Pipeline Products & Ongoing Clinical Trials Overview

    • 5.11 Integra LifeSciences Holdings Corp Company Overview

      • 5.11.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.12 Intelligent Implants Company Overview

      • 5.12.1 Intelligent Implants Pipeline Products & Ongoing Clinical Trials Overview

    • 5.13 Maxigen Biotech Inc Company Overview

      • 5.13.1 Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.14 MicroPort Scientific Corp Company Overview

      • 5.14.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.15 OrthoPediatrics Corp Company Overview

      • 5.15.1 OrthoPediatrics Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.16 Osseus Fusion Systems LLC Company Overview

      • 5.16.1 Osseus Fusion Systems LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.17 OxSonics Ltd Company Overview

      • 5.17.1 OxSonics Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.18 Safe SA Company Overview

      • 5.18.1 Safe SA Pipeline Products & Ongoing Clinical Trials Overview

    • 5.19 SeaSpine, Inc. Company Overview

      • 5.19.1 SeaSpine, Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.20 Spinal Balance Inc. Company Overview

      • 5.20.1 Spinal Balance Inc. Pipeline Products & Ongoing Clinical Trials Overview

    • 5.21 Stryker Corp Company Overview

      • 5.21.1 Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview

    • 5.22 SurGenTec LLC Company Overview

      • 5.22.1 SurGenTec LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.23 The Chaim Sheba Medical Center Company Overview

      • 5.23.1 The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview

    • 5.24 University of South Florida Company Overview

      • 5.24.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview

    • 5.25 University of Toledo Company Overview

      • 5.25.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview

    • 5.26 Vivonics Inc Company Overview

      • 5.26.1 Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.27 ZuriMED Technologies AG Company Overview

      • 5.27.1 ZuriMED Technologies AG Pipeline Products & Ongoing Clinical Trials Overview

  • 6 Minimal Invasive Spinal Devices- Recent Developments

  • 7 Appendix

    • 7.1 Methodology

    • 7.2 About GlobalData

    • 7.3 Contact Us

    • 7.4 Disclaimer

Table

Minimal Invasive Spinal Devices – Pipeline Products by Stage of Development 10

Minimal Invasive Spinal Devices – Pipeline Products by Segment 11

Minimal Invasive Spinal Devices – Pipeline Products by Territory 12

Minimal Invasive Spinal Devices – Pipeline Products by Regulatory Path 13

Minimal Invasive Spinal Devices – Pipeline Products by Estimated Approval Date 14

Minimal Invasive Spinal Devices – Ongoing Clinical Trials 15

Minimal Invasive Spinal Devices Companies – Pipeline Products by Stage of Development 16

Minimal Invasive Spinal Devices – Pipeline Products by Stage of Development 18

Bonovo Orthopedics Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Pioneer QUANTUM Spinal Rodding System – Product Status 19

Pioneer QUANTUM Spinal Rodding System – Product Description 19

Camber Spine Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 20

SPIRA Posterior Lumbar – Product Status 20

SPIRA Posterior Lumbar – Product Description 20

Corelink LLC Pipeline Products & Ongoing Clinical Trials Overview 21

Stand Alone Cervical Cage System – Product Status 21

Stand Alone Cervical Cage System – Product Description 21

CTL Amedica Corp Pipeline Products & Ongoing Clinical Trials Overview 22

Minimally Invasive Flex Tower – Product Status 22

Minimally Invasive Flex Tower – Product Description 22

DePuy Synthes Inc Pipeline Products & Ongoing Clinical Trials Overview 23

Expandable Cage – Spine – Product Status 23

Expandable Cage – Spine – Product Description 23

Next Gen Spine MIS System – Product Status 24

Next Gen Spine MIS System – Product Description 24

Discure Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 25

Bioelectric Implant – Product Status 25

Bioelectric Implant – Product Description 25

EIT Emerging Implant Technologies GmbH Pipeline Products & Ongoing Clinical Trials Overview 26

Fully Printed Lateral Expanding Cage – Product Status 26

Fully Printed Lateral Expanding Cage – Product Description 26

H. Lee Moffitt Cancer Center & Research Institute Inc Pipeline Products & Ongoing Clinical Trials Overview 27

Laterally Expanding Cage – Product Status 27

Laterally Expanding Cage – Product Description 27

Implanet SA Pipeline Products & Ongoing Clinical Trials Overview 28

Jazz Claw Connector – Product Status 28

Jazz Claw Connector – Product Description 29

Jazz Claw System – Product Status 29

Jazz Claw System – Product Description 29

JAZZ Frame System – Product Status 30

JAZZ Frame System – Product Description 30

Inion Oy Pipeline Products & Ongoing Clinical Trials Overview 31

Lumbar Cage – Product Status 31

Lumbar Cage – Product Description 31

Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 32

ESS+ Rod – Product Status 32

ESS+ Rod – Product Description 32

Intelligent Implants Pipeline Products & Ongoing Clinical Trials Overview 33

SmartFuse System – Product Status 33

SmartFuse System – Product Description 33

Intelligent Implants – Ongoing Clinical Trials Overview 34

SmartFuse System – Pivotal Study to Assess the Efficacy of the SmartFuse System 35

Maxigen Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 36

MaxiCage – Product Status 36

MaxiCage – Product Description 36

MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 37

Cannulated Screw – Product Status 37

Cannulated Screw – Product Description 37

OrthoPediatrics Corp Pipeline Products & Ongoing Clinical Trials Overview 38

Growing Rod – Product Status 38

Growing Rod – Product Description 38

Osseus Fusion Systems LLC Pipeline Products & Ongoing Clinical Trials Overview 39

Next Generation Aries – Cervical – Product Status 39

Next Generation Aries – Cervical – Product Description 39

Next Generation Aries – Expandable Lumbar Fusion Cage – Product Status 40

Next Generation Aries – Expandable Lumbar Fusion Cage – Product Description 40

OxSonics Ltd Pipeline Products & Ongoing Clinical Trials Overview 41

UltraSpine – Product Status 41

UltraSpine – Product Description 41

Safe SA Pipeline Products & Ongoing Clinical Trials Overview 42

Oak screw – Cemetable Version – Product Status 42

Oak screw – Cemetable Version – Product Description 42

SeaSpine, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43

PROW – Degenerative Disc Disease – Product Status 43

PROW – Degenerative Disc Disease – Product Description 43

PROW – Herniated Disc – Product Status 44

PROW – Herniated Disc – Product Description 44

PROW – Spinal Tumor – Product Status 44

PROW – Spinal Tumor – Product Description 45

PROW – Spondylolisthesis – Product Status 45

PROW – Spondylolisthesis – Product Description 45

PROW Implant – Trauma – Product Status 46

PROW Implant – Trauma – Product Description 46

Spinal Balance Inc. Pipeline Products & Ongoing Clinical Trials Overview 47

Interbody Cage – Product Status 47

Interbody Cage – Product Description 47

Stryker Corp Pipeline Products & Ongoing Clinical Trials Overview 48

Xia Cannulated Polyaxial Screw – Product Status 48

Xia Cannulated Polyaxial Screw – Product Description 48

SurGenTec LLC Pipeline Products & Ongoing Clinical Trials Overview 49

Ion Facet Screw System – Product Status 49

Ion Facet Screw System – Product Description 49

The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview 50

Transarticular Cannulated Fenestrated Screw – Product Status 50

Transarticular Cannulated Fenestrated Screw – Product Description 50

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 51

Vertebral Body Cage – Product Status 51

Vertebral Body Cage – Product Description 51

University of Toledo Pipeline Products & Ongoing Clinical Trials Overview 52

Minimally Invasive Intervertebral Cage – Product Status 52

Minimally Invasive Intervertebral Cage – Product Description 52

Self-Expanding Inter-Vertebral Cage – Product Status 53

Self-Expanding Inter-Vertebral Cage – Product Description 53

Vivonics Inc Pipeline Products & Ongoing Clinical Trials Overview 54

Midis Cage – Product Status 54

Midis Cage – Product Description 54

ZuriMED Technologies AG Pipeline Products & Ongoing Clinical Trials Overview 55

Surgical-Fiberlock – Herniated Lumbar Disc – Product Status 55

Surgical-Fiberlock – Herniated Lumbar Disc – Product Description 55

Glossary 63

Figures

Minimal Invasive Spinal Devices – Pipeline Products by Stage of Development 9

Minimal Invasive Spinal Devices – Pipeline Products by Segment 10

Minimal Invasive Spinal Devices – Pipeline Products by Territory 11

Minimal Invasive Spinal Devices – Pipeline Products by Regulatory Path 12

Minimal Invasive Spinal Devices – Pipeline Products by Estimated Approval Date 13

Minimal Invasive Spinal Devices – Ongoing Clinical Trials 14

Frequently asked questions

Minimal Invasive Spinal Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

Most Popular
$8,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Minimal Invasive Spinal Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Minimal Invasive Spinal Devices reports
Medical Devices
New
Regulatory Approved Apps Market Size by Segments, Share, Regulatory, Reimbursement,…
$7,500 | September 2026
Medical Devices
New
Non-Invasive Ventilation Masks and Circuits Market Size by Segments, Share,…
$7,500 | September 2026
Medical Devices
New
Insulin Pumps and Continuous Glucose Monitors Market Size by Segments,…
$7,500 | September 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Minimal Invasive Spinal Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Minimal Invasive Spinal Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more